Get started
Author

Sarah Mulholland

Observed names: S Mulholland, S. Mulholland
Observed institutions: North Bristol NHS Trust, University of Exeter, Southmead Hospital, At Bristol, Torbay Hospital, University of Bristol
ORCID: 0009-0001-3758-4164
Observed ORCID: 0009-0001-3758-4164
OpenAlex ID: A5042705895
South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
2018 · Shaney L. Barratt, Sarah Mulholland, et al. · Frontiers in Pharmacology · 47
PDF
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
2022 · Lavanya Raman, Iain Stewart, et al. · ERJ Open Research · 41
PDF
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
2020 · Sabrina Zulfikar, Sarah Mulholland, et al. · Clinical Pharmacology Advances and Applications · 38
PDF
Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs
2018 · Shaney L Barratt, Michelle Morales, et al. · BMJ Open Respiratory Research · 34
PDF
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
2024 · Giles Dixon, Samuel Hague, et al. · ERJ Open Research · 31
PDF
Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases
2021 · Toby Peter Speirs, Nicole Tuffin, et al. · BJGP Open · 12
PDF
The role of the clinical pharmacist in the respiratory or sleep multidisciplinary team
2023 · Jessica Clements, Elaine Bowman, et al. · Breathe · 7
PDF
Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the British Thoracic Society, Interstitial Lung Disease registry data
2025 · S. Mulholland, G. Dixon, et al. · BMJ Open Respiratory Research · 5
PDF
Interventions to address supportive care needs of people with pulmonary fibrosis and/or their caregivers: A scoping review
2025 · Naa-Dromoh Quarshie, Matthew Wells, et al. · Palliative Medicine · 3
PDF
Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding
2019 · Jonathan Wayland Graham, Siba Prosad Paul, et al. · Indian Journal of Clinical Biochemistry · 3
PDF
Validation of pre-flight algorithms in predicting hypoxic challenge testing (HCT) outcomes in interstitial lung disease (ILD)
2026 · Cameron Bonthrone, Beyazit Durdu, et al. · Therapeutic Advances in Respiratory Disease · 2
S9 National UK experience of the treatment of progressive fibrosing interstitial lung disease with nintedanib
2023 · G Dixon, S Hague, et al. · Thorax · 1
PDF
Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease
2023 · Giles Dixon, Samuel Hague, et al. · European Respiratory Journal · 1
Validation of pre-flight algorithms in predicting Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)
2026 · Cameron Bonthrone, Beyazit Durduu, et al. · European Respiratory Journal
Experience of the R421 genetic testing panel from a UK specialist ILD centre
2026 · Hamza Khalique, Alice Parker, et al. · European Respiratory Journal
Author response for "Validation of pre-flight algorithms in predicting Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)"
2026 · Cameron Bonthrone, Beyazit Durdu, et al. · Publons reviews and discussion
Author response for "Validation of pre-flight algorithms in predicting Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD)"
2025 · Cameron Bonthrone, Beyazit Durdu, et al. · Publons reviews and discussion
P102 Strength in partnership: advancing ILD care through collaboration
2025 · M Koulopoulou, A Fahim, et al. · Thorax
S15 The role of quantitative CT in the prognostication and monitoring of systemic autoimmune rheumatic disease related interstitial lung disease
2025 · G Dixon, HI Adamali, et al. · Thorax
M32 A novel pathway for pharmacist-led stepwise de-escalation of background asthma therapy in patients stable on biologics. Experience from Bristol complex airways service
2025 · H Sakota, GW Nava, et al. · Thorax
S13 Quantitative CT is associated with progression free survival in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis
2025 · G Dixon, HI Adamali, et al. · Thorax
Sex differences in a UK Idiopathic Pulmonary Fibrosis (IPF) population: analysis of the British Thoracic Society (BTS) Interstitial Lung Disease (ILD) Registry
2025 · Sarah Mulholland, Giles Dixon, et al. · European Respiratory Journal
Retrospective, multicentre (UK) analysis of bleeding risk from nintedanib with or without concomitant anticoagulation in fibrotic ILD patients
2025 · Nixon Leung, Randeep Karwal, et al. · European Respiratory Journal
Prognostic factors differ in patients commencing antifibrotics for idiopathic pulmonary fibrosis versus progressive pulmonary fibrosis.
2025 · Gabriella Marina Ruffino, Giles Dixon, et al. · European Respiratory Journal
Impact of Interstitial Lung Disease Interdisciplinary Network (ILD-IN) membership on healthcare professionals and clinical practice
2025 · Marium Naqvi, Doria Barbonchielli, et al. · European Respiratory Journal
Works count: 29
Citation count: 225
H-index: 7
I10-index: 6
Year
Topic
Type